Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $1,349,130 | – | $1,273,721 | $1,299,744 |
| % Growth | – | – | -2% | – |
| Cost of Goods Sold | $160,132 | – | $140,496 | $152,566 |
| Gross Profit | $1,188,998 | – | $1,133,225 | $1,147,178 |
| % Margin | 88.1% | – | 89% | 88.3% |
| R&D Expenses | $261,792 | – | $263,663 | $271,523 |
| G&A Expenses | $286,529 | – | $0 | $0 |
| SG&A Expenses | $647,240 | – | $604,852 | $612,841 |
| Sales & Mktg Exp. | $360,711 | – | $0 | $0 |
| Other Operating Expenses | $15,007 | – | $0 | $0 |
| Operating Expenses | $924,039 | – | $868,515 | $884,364 |
| Operating Income | $264,959 | – | $264,710 | $262,814 |
| % Margin | 19.6% | – | 20.8% | 20.2% |
| Other Income/Exp. Net | $38,526 | – | $47,769 | -$12,761 |
| Pre-Tax Income | $303,485 | – | $312,479 | $250,053 |
| Tax Expense | $46,993 | – | $48,163 | $48,409 |
| Net Income | $255,018 | – | $261,825 | $200,656 |
| % Margin | 18.9% | – | 20.6% | 15.4% |
| EPS | 2.66 | – | 2.74 | 2 |
| % Growth | – | – | 37% | – |
| EPS Diluted | 2.62 | – | 2.69 | 1.96 |
| Weighted Avg Shares Out | 95,868 | – | 95,544 | 95,794 |
| Weighted Avg Shares Out Dil | 97,479 | – | 97,325 | 97,588 |
| Supplemental Information | – | – | – | – |
| Interest Income | $15,376 | – | $34,077 | $28,086 |
| Interest Expense | $0 | – | $0 | $0 |
| Depreciation & Amortization | $98,597 | – | $87,327 | $95,514 |
| EBITDA | $378,563 | – | $399,806 | $345,567 |
| % Margin | 28.1% | – | 31.4% | 26.6% |